Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
54
TGA:54
Drug Approvals
IRINOTECAN EUGIA irinotecan hydrochloride trihydrate 100 mg/5 mL concentrated injection vial (439214)
- Product Name
- IRINOTECAN EUGIA irinotecan hydrochloride trihydrate 100 mg/5 mL concentrated injection vial
- Approval Date
- Mar 17, 2025
TGA
IRINOTECAN EUGIA irinotecan hydrochloride trihydrate 300 mg/15 mL concentrated injection vial (439216)
- Product Name
- IRINOTECAN EUGIA irinotecan hydrochloride trihydrate 300 mg/15 mL concentrated injection vial
- Approval Date
- Mar 17, 2025
TGA
EUG-IRINOTECAN irinotecan hydrochloride trihydrate 100 mg/5 mL concentrated injection vial (439201)
- Product Name
- EUG-IRINOTECAN irinotecan hydrochloride trihydrate 100 mg/5 mL concentrated injection vial
- Approval Date
- Mar 17, 2025
TGA
EUG-IRINOTECAN irinotecan hydrochloride trihydrate 300 mg/15 mL concentrated injection vial (439199)
- Product Name
- EUG-IRINOTECAN irinotecan hydrochloride trihydrate 300 mg/15 mL concentrated injection vial
- Approval Date
- Mar 17, 2025
TGA
IRINOTECAN EPSL irinotecan hydrochloride trihydrate 100 mg/5 mL concentrated injection vial (439212)
- Product Name
- IRINOTECAN EPSL irinotecan hydrochloride trihydrate 100 mg/5 mL concentrated injection vial
- Approval Date
- Mar 17, 2025
TGA
IRINOTECAN EUGIA irinotecan hydrochloride trihydrate 500 mg/25 mL concentrated injection vial (439213)
- Product Name
- IRINOTECAN EUGIA irinotecan hydrochloride trihydrate 500 mg/25 mL concentrated injection vial
- Approval Date
- Mar 17, 2025
TGA
IRINOTECAN EPSL irinotecan hydrochloride trihydrate 500 mg/25 mL concentrated injection vial (439203)
- Product Name
- IRINOTECAN EPSL irinotecan hydrochloride trihydrate 500 mg/25 mL concentrated injection vial
- Approval Date
- Mar 17, 2025
TGA
EUG-IRINOTECAN irinotecan hydrochloride trihydrate 500 mg/25 mL concentrated injection vial (439202)
- Product Name
- EUG-IRINOTECAN irinotecan hydrochloride trihydrate 500 mg/25 mL concentrated injection vial
- Approval Date
- Mar 17, 2025
TGA
IRINOTECAN EPSL irinotecan hydrochloride trihydrate 300 mg/15 mL concentrated injection vial (439210)
- Product Name
- IRINOTECAN EPSL irinotecan hydrochloride trihydrate 300 mg/15 mL concentrated injection vial
- Approval Date
- Mar 17, 2025
TGA
IRINOTECAN EUGIA irinotecan hydrochloride trihydrate 40 mg/2 mL concentrated injection vial (439215)
- Product Name
- IRINOTECAN EUGIA irinotecan hydrochloride trihydrate 40 mg/2 mL concentrated injection vial
- Approval Date
- Mar 17, 2025
TGA
- Prev
- 1
- 2
- 3
- 4
- 5
- 6
- Next
Clinical Trials
No trials found
News
No news found